Robert A. Davey, PhD
Adjunct Associate Professor
Department of Microbiology & Immunology and Neuroscience
PhD, 1993, University Adelaide, Australia
BSc, 1988, University of Adelaide, Australia
Overview: Cell Biology Murine leukemia viruses; gene therapy; viral entry.
Robert Davey joined UTMB in 2000, coming from Harvard Medical School in Boston, where he was an instructor in medicine. Presently, he is an Associate Professor in the Department of Microbiology and Immunology and a member of the Galveston National
Laboratory as well as the Institute of Human Infection and Immunity. His work has been focused on identification of cellular factors important for establishing infection by retroviruses and more recently, filoviruses. He is trained to work at
BSL4 and operates a multidiscipline laboratory applying modern molecular techniques to these little studied pathogens. This has culminated in a deeper understanding of the entry and cell signaling pathways that are used by viruses to penetrate
the cell membrane and establish infection. His work as been published in Nature and Science and more recently, work with the BSL4 agent, Ebolavirus, has been published in the high-impact journal PLoS pathogens. Other work of note is his study
in 2009, on the use of siRNA to identify host factors important for Ebolavirus infection and drug discovery, which appeared in Drug Development Research and has been cited in the popular literature. His current work has expanded into other BSL4
pathogens including, but not limited to, the arenaviruses (Junin and Lassa fever virus) as well as bunyaviruses and aims to identify new therapeutics for these pathogens.
Search PubMed Database for Publications